# codex advisor artifact

- Provider: codex
- Exit code: 0
- Created at: 2026-06-16T07:31:25.170Z

## Original task

Audit the FOUNDATION (not features) of a retail systematic-trading research+paper-trading system, and tell me honestly where it's weakest and what to shore up BEFORE building more strategy features. Current state:
- Deterministic event engine, backtest=live PARITY proven, KIS paper order round-trips live-verified, risk manager (ATR/caps/kill/daily-loss), pre-trade gate, resilient submit, kill switch, monitoring, paper-forward journal, cost model (verified KOSPI/US rates).
- DATA: KIS (~100-500 daily bars), keyless research provider (Yahoo US ~25yr/symbol, Naver KR ~5yr), a resumable accumulator building a current-constituent S&P500+KOSPI universe over days. NO point-in-time membership, survivorship-biased, single-source per market, NO cross-source validation, no data-quality checks, research data gitignored (not versioned/hashed).
- Evaluation: descriptive backtest + buy&hold benchmark; tested strategies show NO edge (underperform B&H; momentum no risk-adj edge on tiny universe).

The user (correctly) feels the FOUNDATION is shaky. Rank the TOP foundational weaknesses that would silently invalidate research/results, and for each: why it's dangerous + the minimal fix. Cover at least: data quality/correctness validation, survivorship & point-in-time integrity, engine PnL correctness vs an independent reference (not just internal parity), reproducibility/data versioning, cost/slippage realism, look-ahead audit, multiple-testing discipline. Tell me what to prioritize (P0/P1) and what's acceptable-to-defer for a non-commercial retail effort. Be blunt; don't pad. Senior quant + research-infra perspective.

## Final prompt

Audit the FOUNDATION (not features) of a retail systematic-trading research+paper-trading system, and tell me honestly where it's weakest and what to shore up BEFORE building more strategy features. Current state:
- Deterministic event engine, backtest=live PARITY proven, KIS paper order round-trips live-verified, risk manager (ATR/caps/kill/daily-loss), pre-trade gate, resilient submit, kill switch, monitoring, paper-forward journal, cost model (verified KOSPI/US rates).
- DATA: KIS (~100-500 daily bars), keyless research provider (Yahoo US ~25yr/symbol, Naver KR ~5yr), a resumable accumulator building a current-constituent S&P500+KOSPI universe over days. NO point-in-time membership, survivorship-biased, single-source per market, NO cross-source validation, no data-quality checks, research data gitignored (not versioned/hashed).
- Evaluation: descriptive backtest + buy&hold benchmark; tested strategies show NO edge (underperform B&H; momentum no risk-adj edge on tiny universe).

The user (correctly) feels the FOUNDATION is shaky. Rank the TOP foundational weaknesses that would silently invalidate research/results, and for each: why it's dangerous + the minimal fix. Cover at least: data quality/correctness validation, survivorship & point-in-time integrity, engine PnL correctness vs an independent reference (not just internal parity), reproducibility/data versioning, cost/slippage realism, look-ahead audit, multiple-testing discipline. Tell me what to prioritize (P0/P1) and what's acceptable-to-defer for a non-commercial retail effort. Be blunt; don't pad. Senior quant + research-infra perspective.

## Raw output

```text
Your weakest foundation is not the event engine. It is the research truth layer: data correctness, point-in-time integrity, reproducibility, and independent PnL validation.

Right now the system may be operationally solid but scientifically fragile. You can place paper orders safely, but you cannot yet trust a positive backtest if one appears.

**Priority Ranking**

| Priority | Weakness | Why It Can Silently Invalidate Results | Minimal Fix |
|---|---|---|---|
| P0 | Data quality and correctness validation | Bad bars, missing sessions, split/dividend mistakes, stale symbols, bad KR/US calendars, currency/price adjustment errors, duplicate bars, and provider quirks can create fake alpha or erase real alpha. Single-source data means you currently have no way to know. | Add automated data-quality checks before research use: missing dates vs exchange calendar, OHLC sanity, volume sanity, duplicate timestamps, extreme returns, corporate-action jumps, stale bars, symbol coverage gaps. Store a quality report per dataset. Cross-check a sample against another source. |
| P0 | Survivorship bias / no point-in-time universe | Current S&P 500 + KOSPI constituents exclude delisted losers and past members. This usually inflates trend/momentum/quality/low-vol results and can make weak strategies look real. | For now, label all universe tests explicitly “survivorship-biased exploratory only.” For serious research, build or buy point-in-time membership. Minimal partial fix: test on broad ETFs or indices first, or use static current-universe only for robustness smoke tests, not claims. |
| P0 | Independent PnL correctness | Backtest-live parity proves consistency, not correctness. If both paths share the same accounting bug, parity just proves the bug is deterministic. | Build an independent reference backtester/accounting harness for simple cases. Compare trade-by-trade cash, position, fees, slippage, realized/unrealized PnL, dividends if applicable. Use hand-calculated fixtures: long, short if supported, partial fills, gap opens, limit/market orders, fees, FX, split-adjusted data. |
| P0 | Look-ahead audit | Look-ahead bugs are easy: using same-day close to trade same-day close, adjusted prices with future corporate actions, universe membership known in advance, benchmark alignment mistakes, ATR computed with current bar included. | Add explicit timestamp semantics. Every signal must declare data availability time and execution time. Write tests that fail if today’s close influences today’s order unless the model assumes next-bar execution. Audit all indicators for `.shift(1)` or equivalent. |
| P0 | Reproducibility / data versioning | If research data is gitignored and unhashed, you cannot reproduce a result, compare experiments honestly, or debug why a strategy changed. This kills research credibility. | Do not necessarily commit raw data to git, but version it. Save immutable dataset snapshots with manifest: provider, symbol list, date range, download timestamp, code commit, config, row counts, content hashes, corporate-action/adjustment mode. Every backtest should record the manifest ID. |
| P1 | Cost and slippage realism | Verified commission/tax rates are good, but cost model without realistic spread, market impact, borrow constraints, FX, latency, and fill assumptions can overstate edge, especially in Korean equities and smaller names. | Add conservative slippage assumptions by market/liquidity bucket. At minimum: bps spread/slippage by ADV bucket, worse fills on open/close, no fills above participation cap, reject illiquid names. Run all candidate strategies under pessimistic costs. |
| P1 | Multiple-testing discipline | Once you start trying strategies, parameters, filters, universes, and time windows, false positives become inevitable. A “good” backtest after many attempts is usually noise. | Maintain an experiment log. Define train/validation/test periods before testing. Keep a locked holdout. Report number of trials. Prefer simple strategy families with few degrees of freedom. Use walk-forward or anchored out-of-sample checks. |
| P1 | Corporate actions and total-return handling | Price-only data can punish dividend strategies and distort long-horizon comparisons. Adjusted-close handling differs by provider. KR data may be especially inconsistent. | Decide and document whether you trade adjusted or raw prices. For research, use properly adjusted OHLCV or total-return series where possible. Add split/dividend jump checks. Compare adjusted returns against known ETF/index returns for sanity. |
| P1 | Universe/liquidity tradability filters | A strategy may pick names that were technically in the dataset but not realistically tradable: halted, tiny volume, price limits, suspended, delisted, unavailable through broker, or too illiquid. | Add minimum price, ADV, turnover, listing-age, and suspension/missing-data filters. Make them point-in-time when possible. For now, use conservative current liquidity filters and disclose the limitation. |
| P2 | Benchmarking depth | Buy-and-hold benchmark is necessary but insufficient. Some strategies just repackage beta, size, sector, country, currency, or volatility exposure. | Add market ETF benchmark, equal-weight benchmark, cash benchmark, volatility-adjusted benchmark, and simple factor diagnostics where feasible. Not urgent before data integrity, but needed before believing edge. |

**Blunt Assessment**

The system sounds execution-safe but not yet research-safe.

Your strongest parts are operational: deterministic engine, backtest/live parity, paper order round trips, pre-trade gates, risk manager, kill switch, monitoring, paper journal. That is good infrastructure.

But the main failure mode now is: you may eventually find a “profitable” strategy, and it may be entirely caused by data errors, survivorship bias, look-ahead, cost optimism, or repeated testing. Those are not feature gaps. They are foundation gaps.

**What To Shore Up First**

1. **Data validation pipeline**
   
   Build this before more strategy work. Every dataset should produce a pass/fail quality report.

   Minimum checks:
   - Missing trading days vs exchange calendar.
   - Duplicate bars.
   - Non-positive prices or volume.
   - `high < low`, `open/high/low/close` inconsistencies.
   - Extreme daily returns.
   - Long stale-price runs.
   - Missing volume.
   - Symbol coverage start/end gaps.
   - Split-like jumps.
   - Provider download timestamp and row counts.

2. **Dataset manifests and reproducibility**
   
   You do not need to commit raw research data, but every backtest must be reproducible.

   Minimum manifest:
   - Dataset ID.
   - Provider.
   - Symbols.
   - Date range.
   - Download timestamp.
   - Adjustment mode.
   - File hashes.
   - Strategy config hash.
   - Code commit.
   - Cost model version.

3. **Independent PnL/accounting reference**
   
   Do not rely only on internal parity. Create boring fixture tests with known expected results.

   Minimum cases:
   - Buy one share, hold, sell.
   - Multiple fills.
   - Partial fills.
   - Fees/taxes.
   - Slippage.
   - Cash exhaustion.
   - Position sizing caps.
   - Gap execution at next open.
   - No trade on missing bar.
   - Corporate-action adjusted series, if used.

4. **Look-ahead and timestamp audit**
   
   This is mandatory.

   Make these explicit:
   - Signal observation time.
   - Order submission time.
   - Execution price source.
   - Bar availability assumption.
   - Indicator warmup behavior.
   - Universe membership availability date.

   Default should be: signal from completed bar, trade no earlier than next bar.

5. **Survivorship handling**
   
   This is the hardest one. You can defer full PIT membership only if you also downgrade your claims.

   Acceptable retail compromise:
   - Use current-universe tests only as exploratory.
   - Do not treat them as proof of edge.
   - Prefer ETF/index-level strategy validation where survivorship is less toxic.
   - For single-name equity strategies, eventually obtain point-in-time constituents and delisted names.

**What Is Acceptable To Defer**

For a non-commercial retail system, you can defer:

- Full institutional-grade point-in-time fundamentals.
- Tick-level simulation.
- Full order-book slippage modeling.
- Intraday latency modeling.
- Borrow availability and locate modeling, if long-only.
- Sophisticated factor attribution.
- Professional data warehouse tooling.
- Full multi-provider redundancy for every symbol.

But you should not defer:

- Basic data QA.
- Dataset versioning/hashing.
- Look-ahead audit.
- Independent accounting/PnL tests.
- Conservative slippage assumptions.
- Clear labeling of survivorship-biased tests.
- Experiment tracking.

**Practical P0/P1 Roadmap**

**P0 before new strategies:**
1. Add data QA reports.
2. Add dataset manifests and hashes.
3. Add independent PnL fixture tests.
4. Add timestamp/look-ahead tests.
5. Mark current-universe equity tests as survivorship-biased exploratory.

**P1 before trusting any discovered edge:**
1. Add conservative slippage/liquidity model.
2. Add experiment registry.
3. Add train/validation/test discipline.
4. Add cross-source spot checks.
5. Add better benchmarks and robustness reports.

**Bottom Line**

Do not build more strategy features yet.

The next unit of progress should be making a bad strategy fail honestly, not making more strategies easy to express. Your execution foundation is ahead of your research foundation. The biggest risk is not losing money because the paper-trading path malfunctions; it is convincing yourself that noise or bad data is alpha.


OpenAI Codex v0.139.0
--------
workdir: /Users/manager/side/makemoney
model: gpt-5.5
provider: openai
approval: never
sandbox: danger-full-access
reasoning effort: none
reasoning summaries: none
session id: 019ecf56-a3b3-7270-9e5d-e2c5dced8e02
--------
user
Audit the FOUNDATION (not features) of a retail systematic-trading research+paper-trading system, and tell me honestly where it's weakest and what to shore up BEFORE building more strategy features. Current state:
- Deterministic event engine, backtest=live PARITY proven, KIS paper order round-trips live-verified, risk manager (ATR/caps/kill/daily-loss), pre-trade gate, resilient submit, kill switch, monitoring, paper-forward journal, cost model (verified KOSPI/US rates).
- DATA: KIS (~100-500 daily bars), keyless research provider (Yahoo US ~25yr/symbol, Naver KR ~5yr), a resumable accumulator building a current-constituent S&P500+KOSPI universe over days. NO point-in-time membership, survivorship-biased, single-source per market, NO cross-source validation, no data-quality checks, research data gitignored (not versioned/hashed).
- Evaluation: descriptive backtest + buy&hold benchmark; tested strategies show NO edge (underperform B&H; momentum no risk-adj edge on tiny universe).

The user (correctly) feels the FOUNDATION is shaky. Rank the TOP foundational weaknesses that would silently invalidate research/results, and for each: why it's dangerous + the minimal fix. Cover at least: data quality/correctness validation, survivorship & point-in-time integrity, engine PnL correctness vs an independent reference (not just internal parity), reproducibility/data versioning, cost/slippage realism, look-ahead audit, multiple-testing discipline. Tell me what to prioritize (P0/P1) and what's acceptable-to-defer for a non-commercial retail effort. Be blunt; don't pad. Senior quant + research-infra perspective.
codex
Your weakest foundation is not the event engine. It is the research truth layer: data correctness, point-in-time integrity, reproducibility, and independent PnL validation.

Right now the system may be operationally solid but scientifically fragile. You can place paper orders safely, but you cannot yet trust a positive backtest if one appears.

**Priority Ranking**

| Priority | Weakness | Why It Can Silently Invalidate Results | Minimal Fix |
|---|---|---|---|
| P0 | Data quality and correctness validation | Bad bars, missing sessions, split/dividend mistakes, stale symbols, bad KR/US calendars, currency/price adjustment errors, duplicate bars, and provider quirks can create fake alpha or erase real alpha. Single-source data means you currently have no way to know. | Add automated data-quality checks before research use: missing dates vs exchange calendar, OHLC sanity, volume sanity, duplicate timestamps, extreme returns, corporate-action jumps, stale bars, symbol coverage gaps. Store a quality report per dataset. Cross-check a sample against another source. |
| P0 | Survivorship bias / no point-in-time universe | Current S&P 500 + KOSPI constituents exclude delisted losers and past members. This usually inflates trend/momentum/quality/low-vol results and can make weak strategies look real. | For now, label all universe tests explicitly “survivorship-biased exploratory only.” For serious research, build or buy point-in-time membership. Minimal partial fix: test on broad ETFs or indices first, or use static current-universe only for robustness smoke tests, not claims. |
| P0 | Independent PnL correctness | Backtest-live parity proves consistency, not correctness. If both paths share the same accounting bug, parity just proves the bug is deterministic. | Build an independent reference backtester/accounting harness for simple cases. Compare trade-by-trade cash, position, fees, slippage, realized/unrealized PnL, dividends if applicable. Use hand-calculated fixtures: long, short if supported, partial fills, gap opens, limit/market orders, fees, FX, split-adjusted data. |
| P0 | Look-ahead audit | Look-ahead bugs are easy: using same-day close to trade same-day close, adjusted prices with future corporate actions, universe membership known in advance, benchmark alignment mistakes, ATR computed with current bar included. | Add explicit timestamp semantics. Every signal must declare data availability time and execution time. Write tests that fail if today’s close influences today’s order unless the model assumes next-bar execution. Audit all indicators for `.shift(1)` or equivalent. |
| P0 | Reproducibility / data versioning | If research data is gitignored and unhashed, you cannot reproduce a result, compare experiments honestly, or debug why a strategy changed. This kills research credibility. | Do not necessarily commit raw data to git, but version it. Save immutable dataset snapshots with manifest: provider, symbol list, date range, download timestamp, code commit, config, row counts, content hashes, corporate-action/adjustment mode. Every backtest should record the manifest ID. |
| P1 | Cost and slippage realism | Verified commission/tax rates are good, but cost model without realistic spread, market impact, borrow constraints, FX, latency, and fill assumptions can overstate edge, especially in Korean equities and smaller names. | Add conservative slippage assumptions by market/liquidity bucket. At minimum: bps spread/slippage by ADV bucket, worse fills on open/close, no fills above participation cap, reject illiquid names. Run all candidate strategies under pessimistic costs. |
| P1 | Multiple-testing discipline | Once you start trying strategies, parameters, filters, universes, and time windows, false positives become inevitable. A “good” backtest after many attempts is usually noise. | Maintain an experiment log. Define train/validation/test periods before testing. Keep a locked holdout. Report number of trials. Prefer simple strategy families with few degrees of freedom. Use walk-forward or anchored out-of-sample checks. |
| P1 | Corporate actions and total-return handling | Price-only data can punish dividend strategies and distort long-horizon comparisons. Adjusted-close handling differs by provider. KR data may be especially inconsistent. | Decide and document whether you trade adjusted or raw prices. For research, use properly adjusted OHLCV or total-return series where possible. Add split/dividend jump checks. Compare adjusted returns against known ETF/index returns for sanity. |
| P1 | Universe/liquidity tradability filters | A strategy may pick names that were technically in the dataset but not realistically tradable: halted, tiny volume, price limits, suspended, delisted, unavailable through broker, or too illiquid. | Add minimum price, ADV, turnover, listing-age, and suspension/missing-data filters. Make them point-in-time when possible. For now, use conservative current liquidity filters and disclose the limitation. |
| P2 | Benchmarking depth | Buy-and-hold benchmark is necessary but insufficient. Some strategies just repackage beta, size, sector, country, currency, or volatility exposure. | Add market ETF benchmark, equal-weight benchmark, cash benchmark, volatility-adjusted benchmark, and simple factor diagnostics where feasible. Not urgent before data integrity, but needed before believing edge. |

**Blunt Assessment**

The system sounds execution-safe but not yet research-safe.

Your strongest parts are operational: deterministic engine, backtest/live parity, paper order round trips, pre-trade gates, risk manager, kill switch, monitoring, paper journal. That is good infrastructure.

But the main failure mode now is: you may eventually find a “profitable” strategy, and it may be entirely caused by data errors, survivorship bias, look-ahead, cost optimism, or repeated testing. Those are not feature gaps. They are foundation gaps.

**What To Shore Up First**

1. **Data validation pipeline**
   
   Build this before more strategy work. Every dataset should produce a pass/fail quality report.

   Minimum checks:
   - Missing trading days vs exchange calendar.
   - Duplicate bars.
   - Non-positive prices or volume.
   - `high < low`, `open/high/low/close` inconsistencies.
   - Extreme daily returns.
   - Long stale-price runs.
   - Missing volume.
   - Symbol coverage start/end gaps.
   - Split-like jumps.
   - Provider download timestamp and row counts.

2. **Dataset manifests and reproducibility**
   
   You do not need to commit raw research data, but every backtest must be reproducible.

   Minimum manifest:
   - Dataset ID.
   - Provider.
   - Symbols.
   - Date range.
   - Download timestamp.
   - Adjustment mode.
   - File hashes.
   - Strategy config hash.
   - Code commit.
   - Cost model version.

3. **Independent PnL/accounting reference**
   
   Do not rely only on internal parity. Create boring fixture tests with known expected results.

   Minimum cases:
   - Buy one share, hold, sell.
   - Multiple fills.
   - Partial fills.
   - Fees/taxes.
   - Slippage.
   - Cash exhaustion.
   - Position sizing caps.
   - Gap execution at next open.
   - No trade on missing bar.
   - Corporate-action adjusted series, if used.

4. **Look-ahead and timestamp audit**
   
   This is mandatory.

   Make these explicit:
   - Signal observation time.
   - Order submission time.
   - Execution price source.
   - Bar availability assumption.
   - Indicator warmup behavior.
   - Universe membership availability date.

   Default should be: signal from completed bar, trade no earlier than next bar.

5. **Survivorship handling**
   
   This is the hardest one. You can defer full PIT membership only if you also downgrade your claims.

   Acceptable retail compromise:
   - Use current-universe tests only as exploratory.
   - Do not treat them as proof of edge.
   - Prefer ETF/index-level strategy validation where survivorship is less toxic.
   - For single-name equity strategies, eventually obtain point-in-time constituents and delisted names.

**What Is Acceptable To Defer**

For a non-commercial retail system, you can defer:

- Full institutional-grade point-in-time fundamentals.
- Tick-level simulation.
- Full order-book slippage modeling.
- Intraday latency modeling.
- Borrow availability and locate modeling, if long-only.
- Sophisticated factor attribution.
- Professional data warehouse tooling.
- Full multi-provider redundancy for every symbol.

But you should not defer:

- Basic data QA.
- Dataset versioning/hashing.
- Look-ahead audit.
- Independent accounting/PnL tests.
- Conservative slippage assumptions.
- Clear labeling of survivorship-biased tests.
- Experiment tracking.

**Practical P0/P1 Roadmap**

**P0 before new strategies:**
1. Add data QA reports.
2. Add dataset manifests and hashes.
3. Add independent PnL fixture tests.
4. Add timestamp/look-ahead tests.
5. Mark current-universe equity tests as survivorship-biased exploratory.

**P1 before trusting any discovered edge:**
1. Add conservative slippage/liquidity model.
2. Add experiment registry.
3. Add train/validation/test discipline.
4. Add cross-source spot checks.
5. Add better benchmarks and robustness reports.

**Bottom Line**

Do not build more strategy features yet.

The next unit of progress should be making a bad strategy fail honestly, not making more strategies easy to express. Your execution foundation is ahead of your research foundation. The biggest risk is not losing money because the paper-trading path malfunctions; it is convincing yourself that noise or bad data is alpha.
tokens used
3,867

```

## Concise summary

Provider completed successfully. Review the raw output for details.

## Action items

- Review the response and extract decisions you want to apply.
- Capture follow-up implementation tasks if needed.
